Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer, and marketer of medical devices and systems for respiratory care, acute care, surgery, and the treatment of obstructive sleep apnea. The company's products are sold in over 120 countries, focusing on improving patient care and outcomes through innovative healthcare solutions and a commitment to 'Care by Design'.
Short position
Fisher & Paykel Healthcare (ASX:FPH) has 0.05% of its shares on issue reported as short positions as of 5 Oct 2026, or about 273,054 shares. Over the past 30 days that figure has fallen 0.08 percentage points, and over 90 days it has fallen 0.12 percentage points. Its highest recorded short interest was 1.28% in June 2018. FPH is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Fisher & Paykel Healthcare (FPH) financials
Results, ratios and statements
Latest result
Year to 31 Mar 2026 (FY26) vs FY25, figures in NZD, the reporting currency
- Revenue
- 2.31Bvs 1.28B (FY25)
- Yahoo Finance, as at 9 Oct 2026
- NPAT
- 468.5Mvs 377.2M (FY25)
- Yahoo Finance, as at 9 Oct 2026
- EPS (diluted)
- 0.79vs 0.64 (FY25)
- Yahoo Finance, as at 9 Oct 2026
- Rev YoY
- +80.3%FY
- EPS YoY
- +24.1%TTM
Key ratios
Year to 31 Mar 2026 (FY); balance sheet at 31 Mar 2026; prices to 9 Oct 2026
- Gross margin
- 63.7%
- Operating margin
- 20.7%
- Net margin
- 20.3%
- FCF margin
- 20.3%
- ROE
- 23.4%
- ROA
- 17.3%
- FCF conversion
- 1.00×
- Net cash (excl. leases)
- NZD 401.3M
- Net debt / EBITDA
- −0.5×
- Current ratio
- 2.3×
- Interest cover
- 46.4×
- Cash dividends paid / net profit
- 53.9%
- Market cap
- $22.55B
- P/E
- n/a (reports in NZD)
- P/B
- n/a (reports in NZD)
Ratios use the reporting currency (NZD); market cap is in AUD. Source: Yahoo Finance, as at 9 Oct 2026.
Financial statements
Figures in NZD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | 2.31B | 1.28B | 1.76B | 1.59B |
| Gross profit | 1.47B | 530.2M | 1.06B | 945.9M |
| Operating income | 477.8M | −371.0M | 254.4M | 240.7M |
| EBITDA | 800.4M | 654.3M | 368.2M | 433.7M |
| EBIT | 641.8M | 514.4M | 253.9M | 334.7M |
| Interest expense | 10.3M | 11.1M | 18.2M | 6.7M |
| Pretax income | 631.5M | 503.3M | 235.7M | 328.0M |
| Tax | 163.0M | 126.1M | 103.1M | 77.7M |
| NPAT | 468.5M | 377.2M | 132.6M | 250.3M |
| Net interest income | −2.1M | −6.8M | −14.9M | −4.1M |
| EPS basic | 0.80 | 0.64 | 0.23 | 0.43 |
| EPS diluted | 0.79 | 0.64 | 0.23 | 0.43 |
| Shares | 587.3M | 583.5M | 584.0M | 579.2M |
Financial reports
The company's own filings, newest first
- FPH to announce half year results on 26 November 2026Half Year Results8 Oct 2026via asx_announcements
- Preliminary Final ReportAnnual Results26 May 2026via asx_announcements
- FPH to announce full year results on 26 May 2026Full Year Results15 Apr 2026via asx_announcements
- FPH Notice of Meeting 2025Financial Report31 Dec 2025via crawler
- Chair Speech 2025Financial Report31 Dec 2025via crawler
- Fisher & Paykel Healthcare - Investor Event 2025 PresentationFinancial Report31 Dec 2025via crawler
- FPH Annual Report 2025Annual Report31 Dec 2025via crawler
- FPH ASM Voting Form 2025Financial Report31 Dec 2025via crawler
- ASM Presentation 2025Financial Report31 Dec 2025via crawler
- View the investor fact sheetFinancial Report31 Dec 2025via crawler
Showing 10 of 21 reports